Home Newsfeeds Roth Capital Downgrades Sierra Wireless to Neutral

Roth Capital Downgrades Sierra Wireless to Neutral

Roth Capital analyst Scott Searle downgrades Sierra Wireless (NASDAQ:SWIR) from Buy to Neutral.

byBenzinga Newsdesk

August 3, 2022

1 minute read

Roth Capital analyst Scott Searle downgrades Sierra Wireless (NASDAQ:SWIR) from Buy to Neutral.

Photronics Shares Trade Lower After Sharing Cautious Q2 Outlook

By Anusuya Lahiri

February 21, 12:52 PM

Photronics, Inc (NASDAQ:PLAB) reported first-quarter revenue growth of 11% year-on-year to $211.1 million, beating the consensus of $201 million. IC…

PLAB

JP Morgan Maintains Neutral on Reinsurance Group, Raises Price Target to $141

By Benzinga Newsdesk

January 6, 12:10 PM

JP Morgan analyst Jimmy Bhullar maintains Reinsurance Group (NYSE:RGA) with a Neutral and raises the price target from $136 to $141.

RGA

Dave & Buster’s Appoints Darin Harper As New Chief Financial Officer, Effective On June 17, 2024; Michael Quartieri, Will Continue To Serve As CFO Until June 16, 2024 To Ensure A Smooth Transition

By Benzinga Newsdesk

April 24, 4:50 PM

Dave & Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave & Buster's" or "the Company"), an owner and operator of entertainment and dining venues, today announced that it has appointed a new Chief Financial

PLAY

BioNTech Achieves Milestone At mRNA-Based Vaccine Manufacturing Site In Rwanda

By Benzinga Newsdesk

December 18, 2:17 PM

Set-up of first BioNTainer as high-tech manufacturing solution for mRNA medicines is a critical step in establishing a resilient vaccine ecosystem in Africa and future pandemic preparednessBioNTech plans to complete all

BNTX

Roth Capital Downgrades Sierra Wireless to Neutral

Related Posts

Photronics Shares Trade Lower After Sharing Cautious Q2 Outlook

JP Morgan Maintains Neutral on Reinsurance Group, Raises Price Target to $141

Dave & Buster’s Appoints Darin Harper As New Chief Financial Officer, Effective On June 17, 2024; Michael Quartieri, Will Continue To Serve As CFO Until June 16, 2024 To Ensure A Smooth Transition

BioNTech Achieves Milestone At mRNA-Based Vaccine Manufacturing Site In Rwanda